These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 19445713)
1. How to find simple and accurate rules for viral protease cleavage specificities. Rögnvaldsson T; Etchells TA; You L; Garwicz D; Jarman I; Lisboa PJ BMC Bioinformatics; 2009 May; 10():149. PubMed ID: 19445713 [TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease. Morikawa K; Gouttenoire J; Hernandez C; Dao Thi VL; Tran HT; Lange CM; Dill MT; Heim MH; Donzé O; Penin F; Quadroni M; Moradpour D Hepatology; 2014 Feb; 59(2):423-33. PubMed ID: 23929719 [TBL] [Abstract][Full Text] [Related]
3. New details of HCV NS3/4A proteinase functionality revealed by a high-throughput cleavage assay. Shiryaev SA; Thomsen ER; Cieplak P; Chudin E; Cheltsov AV; Chee MS; Kozlov IA; Strongin AY PLoS One; 2012; 7(4):e35759. PubMed ID: 22558217 [TBL] [Abstract][Full Text] [Related]
4. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex. Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660 [TBL] [Abstract][Full Text] [Related]
5. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044 [TBL] [Abstract][Full Text] [Related]
6. Mapping natural polymorphisms of hepatitis C virus NS3/4A protease and antiviral resistance to inhibitors in worldwide isolates. López-Labrador FX; Moya A; Gonzàlez-Candelas F Antivir Ther; 2008; 13(4):481-94. PubMed ID: 18672527 [TBL] [Abstract][Full Text] [Related]
7. Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease. Khan M; Rauf W; Habib FE; Rahman M; Iqbal S; Shehzad A; Iqbal M BMC Complement Med Ther; 2022 Apr; 22(1):98. PubMed ID: 35366855 [TBL] [Abstract][Full Text] [Related]
8. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease. Yang SH; Lee CG; Song MK; Sung YC Virology; 2000 Mar; 268(1):132-40. PubMed ID: 10683335 [TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication. Benureau Y; Warter L; Malcolm BA; Martin A Virology; 2010 Oct; 406(2):228-40. PubMed ID: 20701941 [TBL] [Abstract][Full Text] [Related]
10. A Novel Approach to Develop New and Potent Inhibitors for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease: A Computational Approach. Riaz M; Rehman AU; Waqas M; Khalid A; Abdalla AN; Mahmood A; Hu J; Wadood A Molecules; 2023 Jan; 28(3):. PubMed ID: 36770965 [TBL] [Abstract][Full Text] [Related]
11. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A. Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853 [TBL] [Abstract][Full Text] [Related]
12. A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals. Franco S; Clotet B; Martínez MA Virus Res; 2008 Feb; 131(2):260-70. PubMed ID: 18037183 [TBL] [Abstract][Full Text] [Related]
13. Specificity of the hepatitis C virus NS3 serine protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing. Kolykhalov AA; Agapov EV; Rice CM J Virol; 1994 Nov; 68(11):7525-33. PubMed ID: 7933136 [TBL] [Abstract][Full Text] [Related]
14. Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: insights from molecular dynamics simulation, binding free energy calculation and network analysis. Xue W; Wang M; Jin X; Liu H; Yao X Mol Biosyst; 2012 Oct; 8(10):2753-65. PubMed ID: 22833015 [TBL] [Abstract][Full Text] [Related]
15. A 3D structural model and dynamics of hepatitis C virus NS3/4A protease (genotype 4a, strain ED43) suggest conformational instability of the catalytic triad: implications in catalysis and drug resistivity. Rimmert B; Sabet S; Ackad E; Yousef MS J Biomol Struct Dyn; 2014; 32(6):950-8. PubMed ID: 23768174 [TBL] [Abstract][Full Text] [Related]
16. Prediction of substrate specificity in NS3/4A serine protease by biased sequence search threading. Ozdemir Isik G; Ozer AN J Biomol Struct Dyn; 2017 Apr; 35(5):1102-1114. PubMed ID: 27122119 [TBL] [Abstract][Full Text] [Related]
17. [Molecular recognition mechanism and motion of HCV NS3/4A protease with Faldaprevir analogue]. Liang L; Hu J; Du W; Zuo K; Liu W; Gou X Sheng Wu Gong Cheng Xue Bao; 2016 May; 32(5):669-682. PubMed ID: 29019204 [TBL] [Abstract][Full Text] [Related]